chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vascular access placement, Vascular graft
Clinical narrative: PAtient presented to the ED on 12/21/21 for right great toe infection. Vascular surgery was consulted due to CT angio aorta abd through bilateral lower extremity showing right popliteal artery occlusion (left common iliac artery diseased with at least 50% stenosis through the external iliac artery). Vascular (Dr. ) performed right thigh cutdown for angioaccess to bypass graft; right runoff angiogram; balloon angioplasty of popliteal to ATA. She was started on heparin gtt until her INR was therapeutic above 2 on warfarin. ID was consulted on 12/22/21 and recommended antibiotic therapy until discharge (prescribed ceftriaxone 12/21, then transitioned to cefazolin from 12/22-12/29). Patient underwent right first toe amputation, silver bunionectomy on 12/23/21 with Dr. of podiatry. Discharged to step down. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging head normal, Tinnitus
Clinical narrative: Developed tinnitus in left ear and visited Primary Care physician. MRI of head/brain done with no abnormalities detected. Saw ENT provider, who detected no significant hearing loss inconsistent with aging. Treating with Lipoflavanoids and white noise for sleep.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Computerised tomogram thorax abnormal, Condition aggravated, Hypertension, Imaging procedure
Clinical narrative: A week after vaccination, patient was leaving a restaurant with family, she raced kids to the car where she collapsed. Emergency was called,  BP was high respiration rate was high but O2 was low. Patient's vitals recovered after rest, she went  home then symptoms came back when she went up the 7 stairs to get in her house, she called the squad and was taken to the ER at hospital. ER took vitals then did a CT that showed a blood clot in her right lung. ER started medication in IV and patient was admitted due to size of clot. She was airlifted to another hospital . More images were taken at hospital to determine if DVT was present. Patient was at hospital until 02/11/2022. Patient is currently on Eliquis 5mg every 12 hours until August and will follow-up with Dr. and pulmonology at the hospital
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Pulmonary thrombosis, Respiratory rate increased, Syncope
Clinical narrative: A week after vaccination, patient was leaving a restaurant with family, she raced kids to the car where she collapsed. Emergency was called,  BP was high respiration rate was high but O2 was low. Patient's vitals recovered after rest, she went  home then symptoms came back when she went up the 7 stairs to get in her house, she called the squad and was taken to the ER at hospital. ER took vitals then did a CT that showed a blood clot in her right lung. ER started medication in IV and patient was admitted due to size of clot. She was airlifted to another hospital . More images were taken at hospital to determine if DVT was present. Patient was at hospital until 02/11/2022. Patient is currently on Eliquis 5mg every 12 hours until August and will follow-up with Dr. and pulmonology at the hospital
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Ischaemic stroke
Clinical narrative: Patient presented to the ED and was subsequently hospitalized for CVA, ischemic stroke within 6 weeks of receiving covid vaccination.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated, not boosted.   COVID infection breakthrough
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anaemia, Anticoagulant therapy, Asymptomatic COVID-19, Cardiac arrest, Catheterisation cardiac abnormal
Clinical narrative: Patient with Moderna (booster) vaccination 3 days prior to hospitalization who admitted after cardiac arrest and a positive COVID PCR done upon admission (routine admission testing, patient with no COVID s/s).  Patient discharged home, provider discharge note below:  "59 year-old with past medical history of hypertension, hyperlipidemia, coronary artery disease status post NSTEMI (05/2021), and peripheral vascular disease s/p stenting (x2, 2018) admitted after witnessed cardiac arrest. She was resuscitated in the field. She has an extensive cardiac history with multiple cardiac stents, in stent thrombosis, chronic occlusion of right coronary artery, had multiple cardiac interventions, HFrEF with EF 20-25%, history of severe peripheral vascular disease, had multiple surgeries off left lower extremity and also has amputation of the great toe, on eliquis, aspirin and Plavix, continues to smoke, history of alcohol abuse.   Brief Summary of Hospital Stay: She underwent hypothermia protocol. Cardiology was consulted and started amiodarone and placed AICD on 3/29. She had LHC with PCI- 2x DES, mid and distal LAD 03/25/22. Medications reconciled per Cardiology instructions. ASA/plavix/eliquis to proceed for 1 month, then can be de-escalated per cardiology. Will defer this management to their expertise. She is to see  Cardiology in close follow up. Imdur held for borderline low BP. Cardiology/Dr. has cleared the patient for discharge at this time.   I did recommend that she go to a SNF, which the pt declined in favor of going home. She understands that not going to SNF could render additional risks including not limited to falls, medication noncompliance, or worsening of disease which could be life threatening. She still wants to go home despite discussion of these risks.    She required 2 units PRBC for acute anemia which has now stabilized. Iron low, supplementation initiated.   A1C was 6.2. Would recommend this be monitored as she was hyperglycemic with her acute illness.    She was noted to be COVID positive but asymptomatic. "
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Glycosylated haemoglobin normal, Hyperglycaemia, Implantable defibrillator insertion, Percutaneous coronary intervention, Red blood cell transfusion
Clinical narrative: Patient with Moderna (booster) vaccination 3 days prior to hospitalization who admitted after cardiac arrest and a positive COVID PCR done upon admission (routine admission testing, patient with no COVID s/s).  Patient discharged home, provider discharge note below:  "59 year-old with past medical history of hypertension, hyperlipidemia, coronary artery disease status post NSTEMI (05/2021), and peripheral vascular disease s/p stenting (x2, 2018) admitted after witnessed cardiac arrest. She was resuscitated in the field. She has an extensive cardiac history with multiple cardiac stents, in stent thrombosis, chronic occlusion of right coronary artery, had multiple cardiac interventions, HFrEF with EF 20-25%, history of severe peripheral vascular disease, had multiple surgeries off left lower extremity and also has amputation of the great toe, on eliquis, aspirin and Plavix, continues to smoke, history of alcohol abuse.   Brief Summary of Hospital Stay: She underwent hypothermia protocol. Cardiology was consulted and started amiodarone and placed AICD on 3/29. She had LHC with PCI- 2x DES, mid and distal LAD 03/25/22. Medications reconciled per Cardiology instructions. ASA/plavix/eliquis to proceed for 1 month, then can be de-escalated per cardiology. Will defer this management to their expertise. She is to see  Cardiology in close follow up. Imdur held for borderline low BP. Cardiology/Dr. has cleared the patient for discharge at this time.   I did recommend that she go to a SNF, which the pt declined in favor of going home. She understands that not going to SNF could render additional risks including not limited to falls, medication noncompliance, or worsening of disease which could be life threatening. She still wants to go home despite discussion of these risks.    She required 2 units PRBC for acute anemia which has now stabilized. Iron low, supplementation initiated.   A1C was 6.2. Would recommend this be monitored as she was hyperglycemic with her acute illness.    She was noted to be COVID positive but asymptomatic. "
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Resuscitation, SARS-CoV-2 test positive, Stent placement, Therapeutic hypothermia
Clinical narrative: Patient with Moderna (booster) vaccination 3 days prior to hospitalization who admitted after cardiac arrest and a positive COVID PCR done upon admission (routine admission testing, patient with no COVID s/s).  Patient discharged home, provider discharge note below:  "59 year-old with past medical history of hypertension, hyperlipidemia, coronary artery disease status post NSTEMI (05/2021), and peripheral vascular disease s/p stenting (x2, 2018) admitted after witnessed cardiac arrest. She was resuscitated in the field. She has an extensive cardiac history with multiple cardiac stents, in stent thrombosis, chronic occlusion of right coronary artery, had multiple cardiac interventions, HFrEF with EF 20-25%, history of severe peripheral vascular disease, had multiple surgeries off left lower extremity and also has amputation of the great toe, on eliquis, aspirin and Plavix, continues to smoke, history of alcohol abuse.   Brief Summary of Hospital Stay: She underwent hypothermia protocol. Cardiology was consulted and started amiodarone and placed AICD on 3/29. She had LHC with PCI- 2x DES, mid and distal LAD 03/25/22. Medications reconciled per Cardiology instructions. ASA/plavix/eliquis to proceed for 1 month, then can be de-escalated per cardiology. Will defer this management to their expertise. She is to see  Cardiology in close follow up. Imdur held for borderline low BP. Cardiology/Dr. has cleared the patient for discharge at this time.   I did recommend that she go to a SNF, which the pt declined in favor of going home. She understands that not going to SNF could render additional risks including not limited to falls, medication noncompliance, or worsening of disease which could be life threatening. She still wants to go home despite discussion of these risks.    She required 2 units PRBC for acute anemia which has now stabilized. Iron low, supplementation initiated.   A1C was 6.2. Would recommend this be monitored as she was hyperglycemic with her acute illness.    She was noted to be COVID positive but asymptomatic. "
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated, not boosted.   COVID infection breakthrough
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy test, Anaphylactic reaction, Blood immunoglobulin E, Hypersensitivity, Paraesthesia oral
Clinical narrative: whole body urticaria and tingling sensation in tongue and throat, facial swelling started 11/10/2021,  anaphylaxis reaction. Hypersensitivity to foods, clothes, dust, and other. I still have urticaria every day. I have used an epi pen three times since 11/10/2021 because several reactions. test perfomed, unable to determine cause of sensitivity and allergic reaction.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal paraesthesia, Swelling face, Urticaria
Clinical narrative: whole body urticaria and tingling sensation in tongue and throat, facial swelling started 11/10/2021,  anaphylaxis reaction. Hypersensitivity to foods, clothes, dust, and other. I still have urticaria every day. I have used an epi pen three times since 11/10/2021 because several reactions. test perfomed, unable to determine cause of sensitivity and allergic reaction.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Unevaluable event
Clinical narrative: N/A.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Death
Clinical narrative: Person passed away after being diagnosed with COVID-19.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Ear pain, Lethargy, SARS-CoV-2 test positive, Sinusitis
Clinical narrative: I started getting symptoms of ear ache and sinus infection symptoms, lethargic but no temperature. I went to a drug store and got a test with a positive COVID-19 result. I went to my doctor that day and was given antibiotics. These symptoms lasted about 5 days. I went to an urgent care to get a monoclonal antibody infusion on 3/19/2022.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Constipation, Vaccine positive rechallenge
Clinical narrative: Severe constipation within 3 days of 1st vaccine but resolved and I didn't think more about it. Then after the 2nd Covid  vaccine on April 21, I had severe constipation that has not resolved.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Crying, Feeling abnormal, Impaired work ability, Insomnia, Mechanical urticaria
Clinical narrative: Chronic hives since 2nd dose of Moderna vaccination. itching/hives all over body, From the top of my head to the tips of my toes. Heat causing body to have more of a rash/hives/itching. I also have dermatographia now. Zyrtec/Allegra helps control. Topical anti-itch barely helps, only for a few minutes. Ice packs help. Worse at night. Have been dealing with this for several months. No history of allergies/hives/eczema/anything like this before. Prednisone doses have helped (have done 2 rounds of this). PCP has referred me to dermatologist who has helped me figure this out finally. Will be seeing an allergist to help with the intense itching. Hoping they can do injections for the itching. Will not be taking the booster, cannot bear to deal with this itching any longer. This has been miserable. I have been up night crying, missed work, itching my skin off, hoping this will end soon.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria chronic
Clinical narrative: Chronic hives since 2nd dose of Moderna vaccination. itching/hives all over body, From the top of my head to the tips of my toes. Heat causing body to have more of a rash/hives/itching. I also have dermatographia now. Zyrtec/Allegra helps control. Topical anti-itch barely helps, only for a few minutes. Ice packs help. Worse at night. Have been dealing with this for several months. No history of allergies/hives/eczema/anything like this before. Prednisone doses have helped (have done 2 rounds of this). PCP has referred me to dermatologist who has helped me figure this out finally. Will be seeing an allergist to help with the intense itching. Hoping they can do injections for the itching. Will not be taking the booster, cannot bear to deal with this itching any longer. This has been miserable. I have been up night crying, missed work, itching my skin off, hoping this will end soon.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Delivery, Exposure during pregnancy, Precipitate labour, Premature rupture of membranes
Clinical narrative: Patient hospitalized with preterm ROM. "She subsequently went into labor and had a precipitous delivery. She had an uncomplicated SVD of a viable male infant weighing 4 # 4 oz. Her postpartum course was uncomplicated." Of note, patient was covid positive on 1/4/22.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient hospitalized with preterm ROM. "She subsequently went into labor and had a precipitous delivery. She had an uncomplicated SVD of a viable male infant weighing 4 # 4 oz. Her postpartum course was uncomplicated." Of note, patient was covid positive on 1/4/22.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Red blood cell transfusion
Clinical narrative: Patient presented to the hospital for planned outpatient PRBC transfusion. Her blood pressure noted to be very elevated, with systolic 200-220s. Because of that, the hospitalist service got involved. Additional doses of hydralazine and furosemide during the transfusion failed to bring blood pressure down significantly, so she was ultimately admitted for further care. She was provided a 30-day supply of metoprolol, and a new dose of hydralazine at the time of discharge. Hospital admission within 6 weeks of receiving the COVID-19 vaccine.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Audiogram abnormal, COVID-19, Communication disorder, Deafness bilateral, Disturbance in attention
Clinical narrative: Acute bilateral tinnitus developed within one day of receiving  the vaccine, also  associated with some acute hearing loss. Tinnitus is is present bilaterally daily, causing unrelenting and life altering hearing problems. Now causing emotional, mental and physical disruptions in my daily life. Difficulties sleeping, focusing, conversing with others and being present in all situations. 6 weeks post vaccine I was infected with COVID-19, the tinnitus and hearing loss worsened and on day 10 of infection I called for appointment of ENT. She prescribed hi dosage  dexamethasone taper and Acyclovir for 10 days. Repeat audiogram showed some mild improvement in hearing, no improvement in tinnitus.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Loss of personal independence in daily activities, Tinnitus
Clinical narrative: Acute bilateral tinnitus developed within one day of receiving  the vaccine, also  associated with some acute hearing loss. Tinnitus is is present bilaterally daily, causing unrelenting and life altering hearing problems. Now causing emotional, mental and physical disruptions in my daily life. Difficulties sleeping, focusing, conversing with others and being present in all situations. 6 weeks post vaccine I was infected with COVID-19, the tinnitus and hearing loss worsened and on day 10 of infection I called for appointment of ENT. She prescribed hi dosage  dexamethasone taper and Acyclovir for 10 days. Repeat audiogram showed some mild improvement in hearing, no improvement in tinnitus.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, Interchange of vaccine products
Clinical narrative: Patient presented for first dose of COVID -19 vaccine. Patient was screened and counseled about risks, and side effects of vaccine. Patient given appropriate dose of Moderna (Spikevax) for fist dose, .5ml. Nursing staff was informed upon data entry that the patient had already received J&J on August 9, 2021. Nursing staff had overlooked this entry in patient's electronic record. However, Patient did present asking for his first dose and did not disclose any other COVID vaccination.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Antiplatelet therapy, Atrial septal defect, Cerebral infarction, Echocardiogram abnormal, Headache
Clinical narrative: Patient presented to the hospital on 12/12/21 with headaches and visual disturbance. She noticed "blackness" of her peripheral vision in her right eye. Imaging showed evolving left occipital infarct and she was seen by stroke neurology who recommended dual antiplatelet therapy and high-dose statin. Echo with bubble study showed PFO. She was treated with Solu-Medrol, Zosyn, and BiPAP temporarily. She was treated with Zosyn on 12/12-12/13, and then ceftriaxone until 12/15/21. The decision was made to discharge her without further antibiotics or steroids since she is breathing comfortably on room air and does not feel short of breath. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Imaging procedure abnormal, Positive airway pressure therapy, Visual field defect, Visual impairment
Clinical narrative: Patient presented to the hospital on 12/12/21 with headaches and visual disturbance. She noticed "blackness" of her peripheral vision in her right eye. Imaging showed evolving left occipital infarct and she was seen by stroke neurology who recommended dual antiplatelet therapy and high-dose statin. Echo with bubble study showed PFO. She was treated with Solu-Medrol, Zosyn, and BiPAP temporarily. She was treated with Zosyn on 12/12-12/13, and then ceftriaxone until 12/15/21. The decision was made to discharge her without further antibiotics or steroids since she is breathing comfortably on room air and does not feel short of breath. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute left ventricular failure, Blood creatinine abnormal, Blood magnesium decreased, Cardiac failure congestive
Clinical narrative: ED Visit for hypomagnesemia Given this, patient was given 2 L of IV fluid as well as 4 mg of IV magnesium.  His labs were repeated and showed a resolved AKI and his creatinine is now back to baseline and we successfully repleted his magnesium.  Hospital admission for Acute systolic congestive heart failure. He was treated with lasix and cardiology has been consulted. ED visits and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Hypomagnesaemia, Laboratory test abnormal
Clinical narrative: ED Visit for hypomagnesemia Given this, patient was given 2 L of IV fluid as well as 4 mg of IV magnesium.  His labs were repeated and showed a resolved AKI and his creatinine is now back to baseline and we successfully repleted his magnesium.  Hospital admission for Acute systolic congestive heart failure. He was treated with lasix and cardiology has been consulted. ED visits and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hypersensitivity, Illness, Pain in extremity
Clinical narrative: I just got super sick. Ran a fever. My body felt horrible. And my arm felt like I got shot with a gun. After that I started getting allergies I've never had before. It all lasted about a week and a half of not doing good at all and over the next six months the allergies got worse and have continued to get worse since then. I have never had allergy issues before receiving the vaccine.
Age: 10.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Product preparation issue
Clinical narrative: Patient presented for second dose of Pediatric Pfizer Vaccination on 3/30/2022. Patient received 0.2 mL of Pediatric Pfizer vaccine undiluted into Left Deltoid at 1331 on 3/30/2022. Patient left 10 minutes post vaccine with no complaints. RN who administered vaccine (writer) did not realize this mistake until drawing up the rest of the vial and there was not enough for ten doses. Patient tolerated well at time of injection. Patient's guardian was called at 0839 today to inform of this and check on patient. Patient's only complaint at this time is that he has a sore arm. No other concerns or complaints. Patient's MD, was called at 0831 and VM was left to her RN. RN returned call at 0850 and was informed of the situation. RN states that Patient has not been seen for a well check since 2021, so she recommended making that appointment to be seen because they like to see their patient's at least once a year for a well check. Other than this, the Nurse did not recommend anything else unless patient begins having worsening symptoms since a sore arm is normal. Patient's guardian, was called again to be informed of this. Patient's guardian states that she will make an appointment. No other concerns from guardian.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chapped lips, Lip dry, Migraine, Nightmare
Clinical narrative: The minute I got the shot within 5 minutes my lips were tingling and my throat got tight. They were worried. As the days went on it got progressively worse. 9th, lips were dry and split, 10th sense of smell was off. Smelled burnt plastic. More sensitive to smells. 11- massive migraine and nightmares. 16th skin sensitive to touch, burning, itching. throat got tighter they told me not to get my 2nd shot. Different symptoms were experienced each day. On the 14th- it felt like how it was when I first got the chemical exposure.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pain of skin, Paraesthesia oral, Parosmia, Pruritus, Throat tightness
Clinical narrative: The minute I got the shot within 5 minutes my lips were tingling and my throat got tight. They were worried. As the days went on it got progressively worse. 9th, lips were dry and split, 10th sense of smell was off. Smelled burnt plastic. More sensitive to smells. 11- massive migraine and nightmares. 16th skin sensitive to touch, burning, itching. throat got tighter they told me not to get my 2nd shot. Different symptoms were experienced each day. On the 14th- it felt like how it was when I first got the chemical exposure.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Angiotensin converting enzyme normal, Biopsy sclera abnormal, Differential white blood cell count normal, Eye pain, Full blood count normal
Clinical narrative: Woke up on 1/31/22 with left eye red, painful. Was referred to a retina specialist and seen on 2/4/2022. There they took a number of pictures of my eye/retina/optic nerve and took a biopsy of my left eye. They were concered for Acutre Retina Necrosis, vision loss and retinal detachment. On 2/4/22 I was prescribed 2g Valacyclovoir daily and Durezol. Went back into doctors on 2/7/2022 and things had progressed much worse. My vision went from 20/20 to 20/200. I had necrosis of the left retina. I was sent to the Hospital for an emergency Intravitreal Foscarnet. Received biopsy results back that day and was positive for Varicella Zoster Virus (VZV+), also known as the shingles virus.\  I am a healthy 28 Year old female and my doctors believe the COVID booster shot, which I received one month prior, reactivated the dormant VZV virus which attacked my left retina. I went to the lab that day and over the course of the next week to rule out any other cause for this. All lab work came back negative, pointing to the Booster shot once again. I had to receive a second intravit foscarnet on 2/10/22. Treatment has been 6g of Valacyclovoir/day and 40g Prednisone/day. Doctor believes I will need to be on Valacyclovoir for life so the virus does not attack my right eye. Today I have lost all peripheral vision on the left side of my left eye where the necrosis is and will never get that back. I am suffering from black floaers, blurred vision and inflammation. My vision is 20/70 in that eye. I can send all lab work if needed.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: HIV antigen negative, Imaging procedure, Inflammation, Laboratory test normal, Lysozyme
Clinical narrative: Woke up on 1/31/22 with left eye red, painful. Was referred to a retina specialist and seen on 2/4/2022. There they took a number of pictures of my eye/retina/optic nerve and took a biopsy of my left eye. They were concered for Acutre Retina Necrosis, vision loss and retinal detachment. On 2/4/22 I was prescribed 2g Valacyclovoir daily and Durezol. Went back into doctors on 2/7/2022 and things had progressed much worse. My vision went from 20/20 to 20/200. I had necrosis of the left retina. I was sent to the Hospital for an emergency Intravitreal Foscarnet. Received biopsy results back that day and was positive for Varicella Zoster Virus (VZV+), also known as the shingles virus.\  I am a healthy 28 Year old female and my doctors believe the COVID booster shot, which I received one month prior, reactivated the dormant VZV virus which attacked my left retina. I went to the lab that day and over the course of the next week to rule out any other cause for this. All lab work came back negative, pointing to the Booster shot once again. I had to receive a second intravit foscarnet on 2/10/22. Treatment has been 6g of Valacyclovoir/day and 40g Prednisone/day. Doctor believes I will need to be on Valacyclovoir for life so the virus does not attack my right eye. Today I have lost all peripheral vision on the left side of my left eye where the necrosis is and will never get that back. I am suffering from black floaers, blurred vision and inflammation. My vision is 20/70 in that eye. I can send all lab work if needed.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Metabolic function test normal, Mycobacterium tuberculosis complex test negative, Necrotising retinitis, Ocular hyperaemia, Treponema test negative
Clinical narrative: Woke up on 1/31/22 with left eye red, painful. Was referred to a retina specialist and seen on 2/4/2022. There they took a number of pictures of my eye/retina/optic nerve and took a biopsy of my left eye. They were concered for Acutre Retina Necrosis, vision loss and retinal detachment. On 2/4/22 I was prescribed 2g Valacyclovoir daily and Durezol. Went back into doctors on 2/7/2022 and things had progressed much worse. My vision went from 20/20 to 20/200. I had necrosis of the left retina. I was sent to the Hospital for an emergency Intravitreal Foscarnet. Received biopsy results back that day and was positive for Varicella Zoster Virus (VZV+), also known as the shingles virus.\  I am a healthy 28 Year old female and my doctors believe the COVID booster shot, which I received one month prior, reactivated the dormant VZV virus which attacked my left retina. I went to the lab that day and over the course of the next week to rule out any other cause for this. All lab work came back negative, pointing to the Booster shot once again. I had to receive a second intravit foscarnet on 2/10/22. Treatment has been 6g of Valacyclovoir/day and 40g Prednisone/day. Doctor believes I will need to be on Valacyclovoir for life so the virus does not attack my right eye. Today I have lost all peripheral vision on the left side of my left eye where the necrosis is and will never get that back. I am suffering from black floaers, blurred vision and inflammation. My vision is 20/70 in that eye. I can send all lab work if needed.
Age: 28.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Varicella virus test positive, Vision blurred, Visual field defect, Vitreous floaters
Clinical narrative: Woke up on 1/31/22 with left eye red, painful. Was referred to a retina specialist and seen on 2/4/2022. There they took a number of pictures of my eye/retina/optic nerve and took a biopsy of my left eye. They were concered for Acutre Retina Necrosis, vision loss and retinal detachment. On 2/4/22 I was prescribed 2g Valacyclovoir daily and Durezol. Went back into doctors on 2/7/2022 and things had progressed much worse. My vision went from 20/20 to 20/200. I had necrosis of the left retina. I was sent to the Hospital for an emergency Intravitreal Foscarnet. Received biopsy results back that day and was positive for Varicella Zoster Virus (VZV+), also known as the shingles virus.\  I am a healthy 28 Year old female and my doctors believe the COVID booster shot, which I received one month prior, reactivated the dormant VZV virus which attacked my left retina. I went to the lab that day and over the course of the next week to rule out any other cause for this. All lab work came back negative, pointing to the Booster shot once again. I had to receive a second intravit foscarnet on 2/10/22. Treatment has been 6g of Valacyclovoir/day and 40g Prednisone/day. Doctor believes I will need to be on Valacyclovoir for life so the virus does not attack my right eye. Today I have lost all peripheral vision on the left side of my left eye where the necrosis is and will never get that back. I am suffering from black floaers, blurred vision and inflammation. My vision is 20/70 in that eye. I can send all lab work if needed.
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute kidney injury, Anaemia, COVID-19, Culture urine negative, Imaging procedure abnormal
Clinical narrative: Patient up to date on COVID vaccinations who admitted to hospital with COVID positive test (no respiratory issues during stay) for sepsis from UTI and active metastatic cancer.  Provider discharge note below:  "Significant Findings and Invasive Procedures) the patient presented with fever, tachycardia and leukocytosis found to be septic from complicated UTI. Mild hydro on imaging and she has ureteral stent. She also had AKI. aki improved as did fever/wbc. Urology recommended outpatient follow up and early stent exchange but not until out of covid isolation, especially given the fact she has resolution of aki and was feeling improved.   She was given 1u prbc due to symptomatic anemia though she was not far from baseline and without observed hemorrhage. She was offered a second unit given 7.5 hgb and mild tachycardia but she declined.   Will complete 7 day course with cipro, ucx was negative but was collected after cefepime given.   Gen: in NAD. Non toxic. Appears improved. HEENT: mucosa moist CV: borderline tachycardic rate, regular rhythm Resp: clear to auscultation bilaterally Abd: soft Ext: left lower extremity with trace pittign lower extremity edema, right lower extremity without any significant edema Skin: warm, dry Neuro: alert, oriented x4 No flank pain.   Issues Requiring Follow Up: (Who, what, when, and how communicated?) follow up urology for stent exchange in 1-2 weeks."
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Leukocytosis, Metastasis, Neoplasm malignant, Pyrexia, Red blood cell transfusion
Clinical narrative: Patient up to date on COVID vaccinations who admitted to hospital with COVID positive test (no respiratory issues during stay) for sepsis from UTI and active metastatic cancer.  Provider discharge note below:  "Significant Findings and Invasive Procedures) the patient presented with fever, tachycardia and leukocytosis found to be septic from complicated UTI. Mild hydro on imaging and she has ureteral stent. She also had AKI. aki improved as did fever/wbc. Urology recommended outpatient follow up and early stent exchange but not until out of covid isolation, especially given the fact she has resolution of aki and was feeling improved.   She was given 1u prbc due to symptomatic anemia though she was not far from baseline and without observed hemorrhage. She was offered a second unit given 7.5 hgb and mild tachycardia but she declined.   Will complete 7 day course with cipro, ucx was negative but was collected after cefepime given.   Gen: in NAD. Non toxic. Appears improved. HEENT: mucosa moist CV: borderline tachycardic rate, regular rhythm Resp: clear to auscultation bilaterally Abd: soft Ext: left lower extremity with trace pittign lower extremity edema, right lower extremity without any significant edema Skin: warm, dry Neuro: alert, oriented x4 No flank pain.   Issues Requiring Follow Up: (Who, what, when, and how communicated?) follow up urology for stent exchange in 1-2 weeks."
Age: 51.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Tachycardia, Urinary tract infection, White blood cell count abnormal
Clinical narrative: Patient up to date on COVID vaccinations who admitted to hospital with COVID positive test (no respiratory issues during stay) for sepsis from UTI and active metastatic cancer.  Provider discharge note below:  "Significant Findings and Invasive Procedures) the patient presented with fever, tachycardia and leukocytosis found to be septic from complicated UTI. Mild hydro on imaging and she has ureteral stent. She also had AKI. aki improved as did fever/wbc. Urology recommended outpatient follow up and early stent exchange but not until out of covid isolation, especially given the fact she has resolution of aki and was feeling improved.   She was given 1u prbc due to symptomatic anemia though she was not far from baseline and without observed hemorrhage. She was offered a second unit given 7.5 hgb and mild tachycardia but she declined.   Will complete 7 day course with cipro, ucx was negative but was collected after cefepime given.   Gen: in NAD. Non toxic. Appears improved. HEENT: mucosa moist CV: borderline tachycardic rate, regular rhythm Resp: clear to auscultation bilaterally Abd: soft Ext: left lower extremity with trace pittign lower extremity edema, right lower extremity without any significant edema Skin: warm, dry Neuro: alert, oriented x4 No flank pain.   Issues Requiring Follow Up: (Who, what, when, and how communicated?) follow up urology for stent exchange in 1-2 weeks."
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Febrile neutropenia, Hypoxia, Laryngeal cancer
Clinical narrative: Patient underwent palliative tracheostomy surgery 1/18 due to airway obstruction secondary to laryngeal cancer.  Was diagnosed with COVID 3 days PTA by testing at wife's workplace ~1/15, admitted for acute respiratory failure with hypoxia secondary to COVID.  He developed neutropenic fevers 1/19, possibly due to COVID, aspiration pneumonia, or other cause.  One dose filgrastim given with improvement of white blood cell count.  He initially required only humidified air by trach dome, then developed hypoxemia 1/21. Treated with a 10 day course of dexamethasone, symptoms improved. Discharged home on 2/2/22. Hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive airways disorder, Pneumonia aspiration, SARS-CoV-2 test, Tracheostomy, White blood cell count
Clinical narrative: Patient underwent palliative tracheostomy surgery 1/18 due to airway obstruction secondary to laryngeal cancer.  Was diagnosed with COVID 3 days PTA by testing at wife's workplace ~1/15, admitted for acute respiratory failure with hypoxia secondary to COVID.  He developed neutropenic fevers 1/19, possibly due to COVID, aspiration pneumonia, or other cause.  One dose filgrastim given with improvement of white blood cell count.  He initially required only humidified air by trach dome, then developed hypoxemia 1/21. Treated with a 10 day course of dexamethasone, symptoms improved. Discharged home on 2/2/22. Hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Malaise, SARS-CoV-2 test positive
Clinical narrative: patient presented to emergency department on 12/15/21 with shortness of breath patient was admitted for further management of  SOB  patient was found to be covid-19 positive on 12/15/21 patient did require treatment for symptoms associated with covid-19 infection. treatment included remdesvir, and oxygen patient was discharged to home on 12/21/21
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Condition aggravated, Imaging procedure, Laboratory test, Pain
Clinical narrative: Patient with J+J vaccine 03/31/21 who admitted with sickle cell crisis who tested detected for COVID during admission.  Patient without respiratory issues during stay, was admitted for pain control.  Provider discharge summary below:    "61-year-old male with history of hemoglobin S and C disease, presented with sickle cell painful episode.  he was also found to have  COVID.   Brief Summary of Hospital Stay: Pain improved with IV analgesia. Other chronic medical issues remained stable. He will see hematology as opt in 8 days.   His COVID remained asymptomatic other than an initial fever, and he did not require eighty supplemental oxygen nor did he have any pulmonary compromise.  No therapy was therefore warranted.  He has been instructed on proper quarantine precautions to take at home.   Issues Requiring Follow Up: Hematology follow up in 2 days.   I would recommend that his outpatient providers consider outpatient COVID treatment given his risk factors.  Monoclonal antibody therapy may be available.  Otherwise please review imaging and labs as below:"
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test positive, Sickle cell anaemia with crisis
Clinical narrative: Patient with J+J vaccine 03/31/21 who admitted with sickle cell crisis who tested detected for COVID during admission.  Patient without respiratory issues during stay, was admitted for pain control.  Provider discharge summary below:    "61-year-old male with history of hemoglobin S and C disease, presented with sickle cell painful episode.  he was also found to have  COVID.   Brief Summary of Hospital Stay: Pain improved with IV analgesia. Other chronic medical issues remained stable. He will see hematology as opt in 8 days.   His COVID remained asymptomatic other than an initial fever, and he did not require eighty supplemental oxygen nor did he have any pulmonary compromise.  No therapy was therefore warranted.  He has been instructed on proper quarantine precautions to take at home.   Issues Requiring Follow Up: Hematology follow up in 2 days.   I would recommend that his outpatient providers consider outpatient COVID treatment given his risk factors.  Monoclonal antibody therapy may be available.  Otherwise please review imaging and labs as below:"
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Delivery, Exposure during pregnancy, Foetal non-stress test normal
Clinical narrative: Patient delivered by NST on 3/21/2022 without complication and was stable post delivery.  She had a 7# 9oz, male infant. Hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Anaphylactoid reaction, Biopsy intestine abnormal, Blindness, Cognitive disorder, Drug hypersensitivity
Clinical narrative: Mast cell activation disorder. Increasing allergy, intolerance, and anaphylactoid reactions to foods and drugs.  Tachycardia, cognitive impairment, vertigo, loss of vision, headache, edema, weight loss, hyperglycemia, itching.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Food allergy, Headache, Histamine level increased, Hyperglycaemia, Mast cell activation syndrome
Clinical narrative: Mast cell activation disorder. Increasing allergy, intolerance, and anaphylactoid reactions to foods and drugs.  Tachycardia, cognitive impairment, vertigo, loss of vision, headache, edema, weight loss, hyperglycemia, itching.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oedema, Pruritus, Tachycardia, Vertigo, Weight decreased
Clinical narrative: Mast cell activation disorder. Increasing allergy, intolerance, and anaphylactoid reactions to foods and drugs.  Tachycardia, cognitive impairment, vertigo, loss of vision, headache, edema, weight loss, hyperglycemia, itching.
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Haematuria, Ultrasound kidney normal
Clinical narrative: The patient developed gross hematuria shortly after receiving his first COVID vaccine. No etiology was found. Of note, he has a bleeding disorder.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: started series with Pfizer & completed series with Janssen
Age: 56.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Acute respiratory failure, Cardiac failure congestive, Dyspnoea, Hypoxia, Lung infiltration
Clinical narrative: Severe sepsis with acute organ dysfunction - acute respiratory failure, metabolic encephalopathy;he developed a LLL infiltrate and was treated for possible bacterial pneumonia with Rocephin, doxycycline and continued on Solu-Medrol and nebulizer treatments.  He had evidence of CHF so he was given IV Lasix during his hospitalization and his oral dose will be increased from 40 to 60 mg daily until his follow-up appointment to address any further adjustments necessary.  He had slow improvement in his symptoms of wheezing, dyspnea and hypoxia and by the time of discharge he only required 1 liter supplemental O2.  ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 56.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Metabolic encephalopathy, Multiple organ dysfunction syndrome, Sepsis, Wheezing
Clinical narrative: Severe sepsis with acute organ dysfunction - acute respiratory failure, metabolic encephalopathy;he developed a LLL infiltrate and was treated for possible bacterial pneumonia with Rocephin, doxycycline and continued on Solu-Medrol and nebulizer treatments.  He had evidence of CHF so he was given IV Lasix during his hospitalization and his oral dose will be increased from 40 to 60 mg daily until his follow-up appointment to address any further adjustments necessary.  He had slow improvement in his symptoms of wheezing, dyspnea and hypoxia and by the time of discharge he only required 1 liter supplemental O2.  ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Anaemia, COVID-19, Condition aggravated, Diverticulum
Clinical narrative: Severely immunocompromised patient due for booster who presented to ED and subsequently admitted with GI and respiratory distress.  Provider discharge note below:  "Brief Summary of Hospital Stay:  Patient is a 53 yo male with history of alcoholic cirrhosis and hepatocellular carcinoma, hemorrhoids who presented with fever and hematochezia and found with acute anemia with Hgb 5.8. Patient was given 2U pRBC with improvement. GI was consulted who recommended ceftriaxone, octreotide and IV protonix due to concern for SBP. These were stopped by discharge following a steady clinical course and paracentesis inconsistent with SBP. Rectal bleeding was suspected to be from diverticulosis and/or hemorrhoids. Patient discharged in stable and improved condition with instructions to follow-up for outpatient colonoscopy and repeat paracentesis.   Patient was noted to be COVID-19 positive on admission despite being vaccinated March/April 2021 and acquiring and recovering from COVID-19 itself in 12/2021. Patient did not show any signs of acute COVID-19 symptoms while inpatient and he was instructed to get a colonoscopy once deemed safe by GI.   He was prescribed iron supplementation for his iron deficiency anemia and Anusol rectal cream for his hemorrhoids on discharge.   He was recommended to have IR outpatient perform a repeat paracentesis but with cytology on discharge."
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Haematochezia, Haemoglobin decreased, Haemorrhoids, Immunodeficiency, Iron deficiency anaemia
Clinical narrative: Severely immunocompromised patient due for booster who presented to ED and subsequently admitted with GI and respiratory distress.  Provider discharge note below:  "Brief Summary of Hospital Stay:  Patient is a 53 yo male with history of alcoholic cirrhosis and hepatocellular carcinoma, hemorrhoids who presented with fever and hematochezia and found with acute anemia with Hgb 5.8. Patient was given 2U pRBC with improvement. GI was consulted who recommended ceftriaxone, octreotide and IV protonix due to concern for SBP. These were stopped by discharge following a steady clinical course and paracentesis inconsistent with SBP. Rectal bleeding was suspected to be from diverticulosis and/or hemorrhoids. Patient discharged in stable and improved condition with instructions to follow-up for outpatient colonoscopy and repeat paracentesis.   Patient was noted to be COVID-19 positive on admission despite being vaccinated March/April 2021 and acquiring and recovering from COVID-19 itself in 12/2021. Patient did not show any signs of acute COVID-19 symptoms while inpatient and he was instructed to get a colonoscopy once deemed safe by GI.   He was prescribed iron supplementation for his iron deficiency anemia and Anusol rectal cream for his hemorrhoids on discharge.   He was recommended to have IR outpatient perform a repeat paracentesis but with cytology on discharge."
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Paracentesis, Pyrexia, Rectal haemorrhage, Red blood cell transfusion, Respiratory distress
Clinical narrative: Severely immunocompromised patient due for booster who presented to ED and subsequently admitted with GI and respiratory distress.  Provider discharge note below:  "Brief Summary of Hospital Stay:  Patient is a 53 yo male with history of alcoholic cirrhosis and hepatocellular carcinoma, hemorrhoids who presented with fever and hematochezia and found with acute anemia with Hgb 5.8. Patient was given 2U pRBC with improvement. GI was consulted who recommended ceftriaxone, octreotide and IV protonix due to concern for SBP. These were stopped by discharge following a steady clinical course and paracentesis inconsistent with SBP. Rectal bleeding was suspected to be from diverticulosis and/or hemorrhoids. Patient discharged in stable and improved condition with instructions to follow-up for outpatient colonoscopy and repeat paracentesis.   Patient was noted to be COVID-19 positive on admission despite being vaccinated March/April 2021 and acquiring and recovering from COVID-19 itself in 12/2021. Patient did not show any signs of acute COVID-19 symptoms while inpatient and he was instructed to get a colonoscopy once deemed safe by GI.   He was prescribed iron supplementation for his iron deficiency anemia and Anusol rectal cream for his hemorrhoids on discharge.   He was recommended to have IR outpatient perform a repeat paracentesis but with cytology on discharge."